BioInvent (BOVNF) Interim Report 1 January – 30 June 2013
7/25/2013 9:19:52 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Important events in the second quarter and after the end of the reporting period
· BioInvent received in July a milestone payment when a partner programme
entered the clinical phase.
· The agreement with Mitsubishi Tanabe Pharma Corporation for research and
development of antibody drugs was extended and expanded.
Help employers find you! Check out all the jobs and post your resume.
comments powered by